Chemotherapy only for localized Hodgkin lymphoma. - Wikidata - awgldk - TriplyDB

Chemotherapy only for localized Hodgkin lymphoma.

Chemotherapy only for localized Hodgkin lymphoma.

http://www.wikidata.org/entity/Q37888802

about

Chemical Reactivity Window Determines Prodrug Efficiency toward Glutathione Transferase Overexpressing Cancer Cells Risk-adapted strategies for the treatment of Hodgkin lymphoma.

P2860

Q28816971-4B8842DA-93E6-4A2A-96DC-A4AEFFDD38B7 Q38591137-B9E303E4-BE4C-43AC-9328-CF904E1B22C1

P2860

Chemotherapy only for localized Hodgkin lymphoma.

http://www.wikidata.org/entity/Q37888802

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 06 July 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Chemotherapy only for localized Hodgkin lymphoma.

@en

Chemotherapy only for localized Hodgkin lymphoma.

@nl

type

label

Chemotherapy only for localized Hodgkin lymphoma.

@en

Chemotherapy only for localized Hodgkin lymphoma.

@nl

prefLabel

Chemotherapy only for localized Hodgkin lymphoma.

@en

Chemotherapy only for localized Hodgkin lymphoma.

@nl

P1433

Q37888802-7F81AF23-CA53-4F50-8668-D06989FED2E2

P1476

Q37888802-7BBAAD06-C233-471F-AB37-08006D12D7C4

P2093

Q37888802-FE381BFA-F1B7-4D4D-8565-7CB81F2C7CCF

P2860

Q37888802-0AC3F9E7-5F7C-4C65-BBA7-5FA291920F47

Q37888802-0CAC5E71-7DC1-4B0A-91DA-FC5AC42DC799

Q37888802-0CB75994-4CDD-41B2-8710-74237906CC8C

Q37888802-11735D4E-408D-4CBE-A235-9E3414D106E7

Q37888802-21BFA23B-84A8-49A6-9BED-771F01D619D7

Q37888802-259CADCC-79C9-4B75-8FD9-C5CFEE64BB58

Q37888802-28C93D2D-40BA-4D48-9F22-E26693273EA2

Q37888802-2A91913C-E0EF-489A-8DB0-2E25B26ED544

Q37888802-2B8268F3-18C7-4E80-BCA1-3F33D2094552

Q37888802-36FF216C-9CEE-4E21-924E-9773903DCCB6

P304

Q37888802-3527DAAD-7D58-47DA-A705-8EE54C836E35

P31

Q37888802-93B5A016-EF4C-4B80-84E5-EC8E1DCD7DC6

P356

Q37888802-9C71EE2E-8F08-44A9-92B5-0BBE03497C71

P407

Q37888802-80D18550-AA19-4E24-A3BB-0A20EB6E8D94

P433

Q37888802-5B11A61C-0735-455D-B514-74EBAA77079E

P478

Q37888802-78BC849C-5531-4468-96D5-662C967A162C

P577

Q37888802-3D6D238A-3009-4CD5-8FE3-1E98555B11BC

P5875

Q37888802-A9927A39-6768-4E80-93B4-FDAFE3573E9A

P698

Q37888802-7DFC4A51-4BE3-4D4F-A06E-27D4EB4F0C0B

P921

Q37888802-C8A516F9-319F-4499-BEB8-69D5D8A60BF2

P356

J.1365-2796.2011.02410.X

P1433

Journal of Internal Medicine

P1476

Chemotherapy only for localized Hodgkin lymphoma.

@en

P2093

D J Straus

http://www.w3.org/2001/XMLSchema#string

P2860

How important is bleomycin in the adriamycin + bleomycin + vinblastine + dacarbazine regimen?

Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin's lymphoma

Treatment of stage I and II Hodgkin's lymphoma with ABVD chemotherapy: results after 7 years of a prospective study

Stroke as a late treatment effect of Hodgkin's Disease: a report from the Childhood Cancer Survivor Study.

Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804.

Early-stage Hodgkin's lymphoma.

Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease.

ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term results.

Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease.

Chronic health conditions in adult survivors of childhood cancer.

P304

197-205

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2796.2011.02410.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

270

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51215044

http://www.w3.org/2001/XMLSchema#string

P698

21668822

http://www.w3.org/2001/XMLSchema#string

P921